Literature DB >> 17362267

Tryptophan metabolism and indoleamine 2,3-dioxygenase expression in coeliac disease.

M I Torres1, M A López-Casado, P Lorite, A Ríos.   

Abstract

We have investigated the possible role of the metabolism of tryptophan and activity of the enzyme indoleamine 2,3-dioxygenase (IDO) in the immune regulation of coeliac disease (CD). Serum concentrations of tryptophan and its metabolites kinurenines were determined by high performance liquid chromatography in 24 patients with CD, seven patients with Crohn's disease and five healthy patients. We detected an increase of kynurenine (4.2 micromol/l +/- 0.27 versus 2.6 micromol/l +/- 0.54, P < 0002) and of the kynurenine/tryptophan ratio in supernatants of coeliac patients (11.5 micromol/l +/- 1.01 versus 6.5 micromol/l +/- 1.57, P < 0005) in comparison with healthy patients, respectively, and we found no differences with Crohn's disease patients. Immunohistochemistry analysis of intestinal biopsies from CD patients showed an increased expression of IDO, interferon-gamma, interleukin-10 and transforming growth factor-beta. Our data suggest that a mechanism(s) dependent on tryptophan catabolism might regulate the immune responses in CD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362267      PMCID: PMC1941917          DOI: 10.1111/j.1365-2249.2007.03365.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

Review 1.  Anti-inflammatory cytokines.

Authors:  S M Opal; V A DePalo
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

Review 2.  Tissue transglutaminase--the key player in celiac disease: a review.

Authors:  Shimon Reif; Aaron Lerner
Journal:  Autoimmun Rev       Date:  2004-01       Impact factor: 9.754

Review 3.  Tryptophan catabolism and regulation of adaptive immunity.

Authors:  Andrew L Mellor; David H Munn
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

4.  Transforming growth factor-beta (TGF-beta) and tissue transglutaminase expression in the small intestine in children with coeliac disease.

Authors:  T Hansson; A-K Ulfgren; E Lindroos; A DannAEus; I Dahlbom; L Klareskog
Journal:  Scand J Immunol       Date:  2002-11       Impact factor: 3.487

5.  New advances in coeliac disease: serum and intestinal expression of HLA-G.

Authors:  M I Torres; M A López-Casado; J Luque; J Peña; A Ríos
Journal:  Int Immunol       Date:  2006-03-28       Impact factor: 4.823

Review 6.  Coeliac disease: dissecting a complex inflammatory disorder.

Authors:  Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

7.  Plasma cytokine profiles in patients with celiac disease and selective IgA deficiency.

Authors:  Francesco Cataldo; Domenico Lio; Vincenzo Marino; Letizia Scola; Antonio Crivello; G R Corazza
Journal:  Pediatr Allergy Immunol       Date:  2003-08       Impact factor: 6.377

8.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Authors:  Catherine Uyttenhove; Luc Pilotte; Ivan Théate; Vincent Stroobant; Didier Colau; Nicolas Parmentier; Thierry Boon; Benoît J Van den Eynde
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

Review 9.  HLA in coeliac disease: unravelling the complex genetics of a complex disorder.

Authors:  A S Louka; L M Sollid
Journal:  Tissue Antigens       Date:  2003-02

Review 10.  HLA-G in cancer: a way to turn off the immune system.

Authors:  Nathalie Rouas-Freiss; Philippe Moreau; Catherine Menier; Edgardo D Carosella
Journal:  Semin Cancer Biol       Date:  2003-10       Impact factor: 15.707

View more
  28 in total

Review 1.  Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.

Authors:  G C Prendergast; M Y Chang; L Mandik-Nayak; R Metz; A J Muller
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies.

Authors:  Olaoluwa Okusaga; Dietmar Fuchs; Gloria Reeves; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Maureen Groer; Thomas B Cook; Kelly A Stearns-Yoder; Janardan P Pandey; Deanna L Kelly; Andrew J Hoisington; Christopher A Lowry; William W Eaton; Lisa A Brenner; Dan Rujescu; Teodor T Postolache
Journal:  Psychosom Med       Date:  2016-10       Impact factor: 4.312

3.  Spectroscopic studies of ligand and substrate binding to human indoleamine 2,3-dioxygenase.

Authors:  Changyuan Lu; Yu Lin; Syun-Ru Yeh
Journal:  Biochemistry       Date:  2010-06-22       Impact factor: 3.162

Review 4.  Gatekeepers of intestinal inflammation.

Authors:  Heather A Arnett; Joanne L Viney
Journal:  Inflamm Res       Date:  2010-01       Impact factor: 4.575

5.  Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity.

Authors:  Nitin K Gupta; Ameet I Thaker; Navya Kanuri; Terrence E Riehl; Christopher W Rowley; William F Stenson; Matthew A Ciorba
Journal:  Inflamm Bowel Dis       Date:  2011-08-05       Impact factor: 5.325

Review 6.  Kynurenines and intestinal neurotransmission: the role of N-methyl-D-aspartate receptors.

Authors:  József Kaszaki; Dániel Erces; Gabriella Varga; Andrea Szabó; László Vécsei; Mihály Boros
Journal:  J Neural Transm (Vienna)       Date:  2011-05-27       Impact factor: 3.575

7.  Navigating the human metabolome for biomarker identification and design of pharmaceutical molecules.

Authors:  Irene Kouskoumvekaki; Gianni Panagiotou
Journal:  J Biomed Biotechnol       Date:  2010-09-28

8.  Molecular Characterization of the Onset and Progression of Colitis in Inoculated Interleukin-10 Gene-Deficient Mice: A Role for PPARalpha.

Authors:  Bianca Knoch; Matthew P G Barnett; Janine Cooney; Warren C McNabb; Diane Barraclough; William Laing; Shuotun Zhu; Zaneta A Park; Paul Maclean; Scott O Knowles; Nicole C Roy
Journal:  PPAR Res       Date:  2010-06-30       Impact factor: 4.964

Review 9.  Indoleamine 2,3 dioxygenase in intestinal disease.

Authors:  Matthew A Ciorba
Journal:  Curr Opin Gastroenterol       Date:  2013-03       Impact factor: 3.287

10.  Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.

Authors:  Pinku Mukherjee; Gargi D Basu; Teresa L Tinder; Durai B Subramani; Judy M Bradley; Million Arefayene; Todd Skaar; Giovanni De Petris
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.